BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17030081)

  • 1. [Surgical management of cutaneous malignant melanoma. Review].
    Lavie A; Desouches C; Casanova D; Bardot J; Grob JJ; Legré R; Magalon G
    Ann Chir Plast Esthet; 2007 Feb; 52(1):1-13. PubMed ID: 17030081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
    Guggenheim MM; Hug U; Jung FJ; Rousson V; Aust MC; Calcagni M; Künzi W; Giovanoli P
    Ann Surg; 2008 Apr; 247(4):687-93. PubMed ID: 18362633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The skin overlying the sentinel lymph node: a full thickness skin graft donor site after local excision for cutaneous melanoma].
    Chennoufi M; Guihard T; Lantieri L
    Ann Chir Plast Esthet; 2007 Feb; 52(1):35-8. PubMed ID: 16857304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care.
    Coldiron BM; Dinehart S; Rogers HW
    Clin Dermatol; 2009; 27(4):350-4. PubMed ID: 19539161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects.
    Lewis JM; Zager JS; Yu D; Pelaez D; Riker AI; Dessureault S; Cruse CW; Reintgen DS; Puleo CA; Sondak VK
    Ann Surg Oncol; 2008 Jun; 15(6):1733-40. PubMed ID: 18379848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination.
    Thompson JF; Scolyer RA; Uren RF
    Surg Oncol Clin N Am; 2006 Apr; 15(2):301-18. PubMed ID: 16632216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical therapy of malignant melanoma of the skin].
    Bachter D
    Praxis (Bern 1994); 2001 Feb; 90(8):307-13. PubMed ID: 11256333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of surgery in the treatment of malignant melanoma].
    Péley G; Farkas E; Mátrai Z; Rényi-Vámos F; Kovács T; Köves I
    Magy Onkol; 2003; 47(1):69-77. PubMed ID: 12704458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel node mapping for melanoma: results of trials and current applications.
    Thompson JF; Shaw HM
    Surg Oncol Clin N Am; 2007 Jan; 16(1):35-54. PubMed ID: 17336235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
    Kruit WH;
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiology of the sentinel node.
    Cochran AJ; Ohsie SJ; Binder SW
    Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should all melanoma patients undergo sentinel lymph node biopsy?
    Ra JH; McMasters KM; Spitz FR
    Curr Opin Oncol; 2006 Mar; 18(2):185-8. PubMed ID: 16462189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous melanoma: therapeutic lymph node and elective lymph node dissections, lymphatic mapping, and sentinel lymph node biopsy.
    Pharis DB
    Dermatol Ther; 2005; 18(6):397-406. PubMed ID: 16297015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
    Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
    Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
    Sabel MS; Griffith KA; Arora A; Shargorodsky J; Blazer DG; Rees R; Wong SL; Cimmino VM; Chang AE
    Surgery; 2007 Jun; 141(6):728-35. PubMed ID: 17560249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
    van Akkooi AC; Bouwhuis MG; de Wilt JH; Kliffen M; Schmitz PI; Eggermont AM
    Br J Surg; 2007 Oct; 94(10):1293-9. PubMed ID: 17702089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of multiple-nodal basin drainage on cutaneous melanoma.
    Federico AC; Chagpar AB; Ross MI; Martin RC; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Sussman JJ; McMasters KM; Scoggins CR;
    Arch Surg; 2008 Jul; 143(7):632-7; discussion 637-8. PubMed ID: 18645103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.